Bio-nanoimaging: Protein Misfolding and Aggregation
Editat de Vladimir N Uversky, Yuri Lyubchenkoen Limba Engleză Hardback – 6 ian 2014
Protein misfolding and aggregation is a fast-growing frontier in molecular medicine and protein chemistry. Related disorders include cataracts, arthritis, cystic fibrosis, late-onset diabetes mellitus, and numerous neurodegenerative diseases like Alzheimer's and Parkinson's. Nanoimaging technology has proved crucial in understanding protein-misfolding pathologies and in potential drug design aimed at the inhibition or reversal of protein aggregation. Using these technologies, researchers can monitor the aggregation process, visualize protein aggregates and analyze their properties.
- Provides practical examples of nanoimaging research from leading molecular biology, cell biology, protein chemistry, biotechnology, genetics, and pharmaceutical labs
- Includes over 200 color images to illustrate the power of various nanoimaging technologies
- Focuses on nanoimaging techniques applied to protein misfolding and aggregation in molecular medicine
Preț: 817.82 lei
Preț vechi: 1140.35 lei
-28% Nou
Puncte Express: 1227
Preț estimativ în valută:
156.61€ • 169.39$ • 130.49£
156.61€ • 169.39$ • 130.49£
Carte tipărită la comandă
Livrare economică 04-18 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780123944313
ISBN-10: 0123944317
Pagini: 552
Ilustrații: 300 illustrations (200 in full color)
Dimensiuni: 216 x 276 x 33 mm
Greutate: 1.73 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0123944317
Pagini: 552
Ilustrații: 300 illustrations (200 in full color)
Dimensiuni: 216 x 276 x 33 mm
Greutate: 1.73 kg
Editura: ELSEVIER SCIENCE
Public țintă
Researchers and post-graduate students studying molecular medicine and molecular basis of disease, biotechnology, nanomedicine, pharmacology and drug discovery, molecular and cellular biology, biochemistry, biophysics, structural biologyCuprins
Part 1. Nanotechnology and nanoimaging of aggregating proteins
Nanoimaging of aggregated proteins; Cryoelectron microscopy of beta(2)-microglobulin; Amyloid fibril length quantification by AFM; Seeing fibril formation in real time; Studying amyloidogensis by FRET; Structure, growth and assembly of amyloid-like fibrils using high-speed atomic force microscopy; Analyzing amyloid fibril structure by scanning transmission electron microscopy; Magic angle spinning NMR of amyloid fibrils; Analyzing protein deposits in vivo by confocal laser multiphoton laser scanning microscopy; Amyloid imaging agents; Reporters of amyloid structure; Immunohistochemical detection of amyloid components; Scanning tunneling microscopy of protein deposits; Probing of protein misfolding with single molecule force spectroscopy; Single molecule characterization of a-synuclein in aggregation-prone states
Part 2. Polymorphism of protein misfolded and aggregated species
Fibrillar polymorphism; Ab fibril polymorphism; Prefibrillar Ab oligomers; Structural heterogeneity of in vitro and ex vivo amyloid assemblies; Polymorphism of tau fibrils; Amyloid-like protofibrils with different physical properties; Micelle-Like Architecture of the Amyloid-ß Peptide; Insulin oligomers; Worm-like amyloid fibrils of mouse prion protein; Apolipoprotein C-II Amyloid Fibrils; Amylin oligomers and fibrils; Amyloid fibrils of human stefins; Fibrillar structure of Sup35 in vivo; Dopamine-induced a-synuclein oligomers ; Amyloid spherulites; A stable lipid-induced aggregate of alpha-synuclein
Part 3. Polymorphism of protein misfolding and aggregation processes
Multiple pathways of lysozyme aggregation; Structure-function study of amyloid ion channels in neurodegenerative diseases; Amyloid ß-protein assembly; Molecular mechanisms underlying alpha synucelin misassembly; Multiple pathways of amyloid assembly /disassembly studied by AFM; Sequestering of metastable proteins with essential cellular functions by amyloid-like aggregates; Misfolded intermediate of a PDZ domain; Structural characterization of the amyloidogenic state of human lysozyme; Landscape Model of Filamentous Protein Aggregation; Micelle formation by human islet amyloid polypeptide; Effect of anionic polysaccharide on ß-lactoglobulin fibrillation
Nanoimaging of aggregated proteins; Cryoelectron microscopy of beta(2)-microglobulin; Amyloid fibril length quantification by AFM; Seeing fibril formation in real time; Studying amyloidogensis by FRET; Structure, growth and assembly of amyloid-like fibrils using high-speed atomic force microscopy; Analyzing amyloid fibril structure by scanning transmission electron microscopy; Magic angle spinning NMR of amyloid fibrils; Analyzing protein deposits in vivo by confocal laser multiphoton laser scanning microscopy; Amyloid imaging agents; Reporters of amyloid structure; Immunohistochemical detection of amyloid components; Scanning tunneling microscopy of protein deposits; Probing of protein misfolding with single molecule force spectroscopy; Single molecule characterization of a-synuclein in aggregation-prone states
Part 2. Polymorphism of protein misfolded and aggregated species
Fibrillar polymorphism; Ab fibril polymorphism; Prefibrillar Ab oligomers; Structural heterogeneity of in vitro and ex vivo amyloid assemblies; Polymorphism of tau fibrils; Amyloid-like protofibrils with different physical properties; Micelle-Like Architecture of the Amyloid-ß Peptide; Insulin oligomers; Worm-like amyloid fibrils of mouse prion protein; Apolipoprotein C-II Amyloid Fibrils; Amylin oligomers and fibrils; Amyloid fibrils of human stefins; Fibrillar structure of Sup35 in vivo; Dopamine-induced a-synuclein oligomers ; Amyloid spherulites; A stable lipid-induced aggregate of alpha-synuclein
Part 3. Polymorphism of protein misfolding and aggregation processes
Multiple pathways of lysozyme aggregation; Structure-function study of amyloid ion channels in neurodegenerative diseases; Amyloid ß-protein assembly; Molecular mechanisms underlying alpha synucelin misassembly; Multiple pathways of amyloid assembly /disassembly studied by AFM; Sequestering of metastable proteins with essential cellular functions by amyloid-like aggregates; Misfolded intermediate of a PDZ domain; Structural characterization of the amyloidogenic state of human lysozyme; Landscape Model of Filamentous Protein Aggregation; Micelle formation by human islet amyloid polypeptide; Effect of anionic polysaccharide on ß-lactoglobulin fibrillation
Recenzii
"Among the topics are conformation-dependent antibodies as tools for characterizing amyloid protein aggregates, studying the molecular determinants of protein oligomerization in neurodegenerative disorders by bimolecular fluorence complimentation, possible function and toxicity of multiple oligomeric/conformational states of the globular protein human stefin B…" --ProtoView.com, February 2014